Relative Bioavailability Of Palbociclib (PD-0332991) Under Fed And Fasted Conditions

Completed · Phase 1

Conditions studied: Healthy

In brief

A relative bioavailability study of commercial palbociclib free base hard capsules to the isethionate salt palbociclib capsules ( used in Phase 1 and 2 studies) under different fasting conditions.

Key facts

Study ID

NCT02041273

Run by

Pfizer

People needed

36

Starts

2014-01-01

Expected to finish

2014-03-01

Last updated by the study team

2014-03-17

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male subjects and/or female subjects of non-childbearing potential between the ages of 18 and 55 years.
• Evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study.

You may not qualify if…

• Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease.
• Any condition possibly affecting drug absorption.

Where it is running

• Pfizer Investigational Site — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.